Want to hear about the latest advances in rheumatoid arthritis (RA), osteoarthritis (OA), systemic lupus erythematosus (SLE) and polymyositis/dermatomyositis and how best to implement interprofessional care for your patients? The Association of Rheumatology Health Professionals (ARHP) Clinical Focus Course (CFC) is the course for you. The CFC is a full-day course titled, Clinical Advances in Rheumatologic Diseases: A Case-based Approach, that will be offered on Nov. 7 just prior to the ACR/ARHP Annual Meeting in San Francisco. This course will offer updates on advances in the diagnosis and clinical management of these conditions in adults and children, and will integrate cases to exemplify best practices.
The course faculty, David A. Isenberg, MD, Lisa G. Rider, MD, Peter Chira, MD, MS, Jessica Farrell, PharmD, and Karen Huisinga, MN, ARNP, are world-renowned experts in their fields. Dr. Farrell, associate professor of Pharmacy Practice at Albany College of Pharmacy and Health Sciences in Albany, N.Y., and a clinical pharmacist with The Center for Rheumatology in Albany and Saratoga Springs, N.Y., will present the update session on RA. Ms. Huisinga, an advanced practice nurse working in rheumatology at the Department of Veterans Affairs Medical Center in Seattle, will present the latest advances in OA, including pathogenesis, clinical diagnosis and interventions. She will also review the current ACR guidelines. Ms. Huisinga has more than 20 years’ experience in rheumatology and has presented on both OA and RA in many forums during her career.
Dr. Isenberg will present the session on adult and pediatric SLE. Dr. Isenberg is an academic director of rheumatology at University College London and has been associated with the SLE cohort at University College Hospital, London (650 patients) since 1979. He is currently chairing the Lupus UK’s Research Committee and a Local Clinical Trials Network Enabling Group in North London. Dr. Isenberg received the 2010 Evelyn V. Hess, MD, MACP, MACR, Award from the Lupus Foundation of America for his outstanding contributions to SLE research.
Dr. Rider will be speaking about the latest developments in adult and pediatric polymyositis and dermatomyositis. She is deputy unit chief of the Environmental Autoimmunity Group in the Clinical Research Branch of the National Institute of Environmental Health Sciences at the National Institutes of Health and is a captain in the U.S. Public Health Service Commissioned Corps. She has more than 20 years’ experience studying autoimmune disease, with a focus on juvenile-onset myositis, and has published and spoken extensively in those areas. She has been leading efforts to develop myositis response criteria.
